Parexel launches China Trials Solution
Global CRO Parexel International has launched Parexel Dĭng Huī, China Trials Solution. The offering combines advanced technology and international SOPs (Standard Operating Procedures) with local experience and resources to deliver cost-effective services that meet global quality standards. Parexel Dĭng Huī will support clients through locally delivered, streamlined services that support single-country registration trials and are tailored to meet Chinese NDA submission requirements.
"Drug manufacturers must follow a mandatory clinical trial process before launching pharmaceutical products in China," said Albert Liou, vice chairman of Parexel International. "Because of the unique, complex and often-lengthy nature of this process, clients are seeking to partner with CROs that truly understand local clinical trial and regulatory requirements and have global experience.”